INI 678
Alternative Names: INI-678Latest Information Update: 02 Sep 2022
At a glance
- Originator Inipharm
- Class Antifibrotics; Hepatoprotectants; Small molecules
- Mechanism of Action 17-hydroxysteroid dehydrogenase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Non-alcoholic steatohepatitis
Most Recent Events
- 22 Jun 2022 Pharmacodynamics data from preclinical trial in Non-alcoholic steatohepatitis presented at The International Liver Congress 2022 (ILC-2022)
- 05 Oct 2021 Preclinical trials in Non-alcoholic steatohepatitis in USA (unspecified route) before October 2021
- 05 Oct 2021 Pharmacodynamics data from preclinical trial in Non-alcoholic steatohepatitis released by Inipharm